Pulmonary hypertension causes: Difference between revisions
Kiran Singh (talk | contribs) |
|||
Line 9: | Line 9: | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Pulmonary hypertension | Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Pulmonary hypertension itself is not a life threatening condition, but it is progressively fatal if left untreated. [[Pulmonary embolism|'''Pulmonary embolism''']] and [[left heart failure|'''acute left heart failure''']] are two causes of pulmonary hypertension that can be quickly fatal. | ||
===Common Causes=== | ===Common Causes=== | ||
Line 34: | Line 34: | ||
=== Causes by Organ System === | === Causes by Organ System === | ||
{|style="width:70%; height:100px" border="1" | {| style="width:70%; height:100px" border="1" | ||
| | | style="width:25%" bgcolor="LightSteelBlue" ; border="1" | '''Cardiovascular''' | ||
| | | style="width:75%" bgcolor="Beige" ; border="1" | [[ASD|Atrial septal defect]], [[cor triatriatum]], [[left heart failure]], [[Fallot tetralogy]], [[persistent fetal circulation]], [[mitral valve stenosis]], [[mitral valve insufficiency]], [[ventricular septal defect]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Chemical / poisoning''' | | '''Chemical / poisoning''' | ||
|bgcolor="Beige"| [[Coal workers' pneumoconiosis]] | | bgcolor="Beige" | [[Coal workers' pneumoconiosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| [[Neurofibromatosis]], [[systemic lupus erythematosus]] | | bgcolor="Beige" | [[Neurofibromatosis]], [[systemic lupus erythematosus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Drug and Toxin Side Effect''' | | '''Drug and Toxin Side Effect''' | ||
|bgcolor="Beige"| Definite: [[Aminorex]], [[Carfilzomib]], [[benfluorex]], [[dexfenfluramine]], [[Diethylpropion]], [[fenfluramine]], toxic [[rapeseed]] oil, [[benfluorex]], <br> Likely: [[Amphetamines]], L-[[tryptophan]], [[methamphetamine]] <br> Possible: [[Cocaine]], [[Lorcaserin]], [[Pegylated interferon alfa-2b]], [[phentermine]], [[phenylpropanolamine]], [[pergolide]],[[Protamine sulfate]],[[St John's wort]], [[chemotherapeutic agents]], [[SSRI]], [[Aprotinin]] | | bgcolor="Beige" | Definite: [[Aminorex]], [[Carfilzomib]], [[benfluorex]], [[dexfenfluramine]], [[Diethylpropion]], [[fenfluramine]], toxic [[rapeseed]] oil, [[benfluorex]], <br> Likely: [[Amphetamines]], L-[[tryptophan]], [[methamphetamine]] <br> Possible: [[Cocaine]], [[Lorcaserin]], [[Pegylated interferon alfa-2b]], [[phentermine]], [[phenylpropanolamine]], [[pergolide]],[[Protamine sulfate]],[[St John's wort]], [[chemotherapeutic agents]], [[SSRI]], [[Aprotinin]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Ear Nose Throat''' | | '''Ear Nose Throat''' | ||
|bgcolor="Beige"| [[Pickwickian syndrome]] | | bgcolor="Beige" | [[Pickwickian syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| [[Thyroid diseases]] | | bgcolor="Beige" | [[Thyroid diseases]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Environmental''' | | '''Environmental''' | ||
|bgcolor="Beige"| [[High altitude sickness|High Altitude (chronically)]] | | bgcolor="Beige" | [[High altitude sickness|High Altitude (chronically)]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| [[Portal hypertension]] | | bgcolor="Beige" | [[Portal hypertension]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Alveolar capillary dysplasia|Alveolar capillary dysplasia with misalignment of pulmonary veins]], [[cholesterol ester storage disease]], [[cystic fibrosis]], [[Gaucher disease]], Indian familial childhood cirrhosis<ref name="pmid23852284">{{cite journal| author=Nayak NC, Chitale AR| title=Indian childhood cirrhosis (ICC) & ICC-like diseases: the changing scenario of facts versus notions. | journal=Indian J Med Res | year= 2013 | volume= 137 | issue= 6 | pages= 1029-42 | pmid=23852284 | doi= | pmc=PMC3734708 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23852284 }} </ref> | | bgcolor="Beige" | [[Alveolar capillary dysplasia|Alveolar capillary dysplasia with misalignment of pulmonary veins]], [[cholesterol ester storage disease]], [[cystic fibrosis]], [[Gaucher disease]], Indian familial childhood cirrhosis<ref name="pmid23852284">{{cite journal| author=Nayak NC, Chitale AR| title=Indian childhood cirrhosis (ICC) & ICC-like diseases: the changing scenario of facts versus notions. | journal=Indian J Med Res | year= 2013 | volume= 137 | issue= 6 | pages= 1029-42 | pmid=23852284 | doi= | pmc=PMC3734708 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23852284 }} </ref> | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| [[Myeloproliferative disorders]], [[paroxysmal nocturnal haemoglobinuria]], [[polycythemia vera]], [[splenectomy]], [[sickle cell disease]] | | bgcolor="Beige" | [[Myeloproliferative disorders]], [[paroxysmal nocturnal haemoglobinuria]], [[polycythemia vera]], [[splenectomy]], [[sickle cell disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| No underlying cause | | bgcolor="Beige" | No underlying cause | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| [[ Kaposi's sarcoma-associated herpesvirus|HHV-8]], [[schistosoma japonicum]] and [[schistosoma mansoni]] | | bgcolor="Beige" | [[ Kaposi's sarcoma-associated herpesvirus|HHV-8]], [[schistosoma japonicum]] and [[schistosoma mansoni]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal / Ortho''' | | '''Musculoskeletal / Ortho''' | ||
|bgcolor="Beige"| [[Scoliosis|Idiopathic spinal scoliosis]] | | bgcolor="Beige" | [[Scoliosis|Idiopathic spinal scoliosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| No underlying cause | | bgcolor="Beige" | No underlying cause | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Nutritional / Metabolic''' | | '''Nutritional / Metabolic''' | ||
|bgcolor="Beige"| No underlying cause | | bgcolor="Beige" | No underlying cause | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| No underlying cause | | bgcolor="Beige" | No underlying cause | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Opthalmologic''' | | '''Opthalmologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Overdose / Toxicity''' | | '''Overdose / Toxicity''' | ||
|bgcolor="Beige"| [[Diethylpropion]], monocrotaline,<ref name="pmid9776954">{{cite journal| author=Schultze AE, Roth RA| title=Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system. | journal=J Toxicol Environ Health B Crit Rev | year= 1998 | volume= 1 | issue= 4 | pages= 271-346 | pmid=9776954 | doi=10.1080/10937409809524557 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9776954 }} </ref> [[phentermine]], [[radiation exposure]] (fibrosing [[mediastinitis]] and [[pulmonary fibrosis]]). | | bgcolor="Beige" | [[Diethylpropion]], monocrotaline,<ref name="pmid9776954">{{cite journal| author=Schultze AE, Roth RA| title=Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system. | journal=J Toxicol Environ Health B Crit Rev | year= 1998 | volume= 1 | issue= 4 | pages= 271-346 | pmid=9776954 | doi=10.1080/10937409809524557 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9776954 }} </ref> [[phentermine]], [[radiation exposure]] (fibrosing [[mediastinitis]] and [[pulmonary fibrosis]]). | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| [[Idiopathic pulmonary hemosiderosis]], [[sarcoidosis]], [[primary pulmonary hypertension]], [[pulmonary fibrosis]], [[alveolar capillary dysplasia|alveolar capillary dysplasia with misalignment of pulmonary veins]], [[cystic fibrosis]], [[pulmonary embolism]], [[tropical pulmonary eosinophilia]], [[pulmonary capillary hemangiomatosis]], [[bronchiectasis]],[[bronchopulmonary dysplasia]], [[chronic obstructive pulmonary disease]], pulmonary alveolar microlithiasis,<ref name="pmid23741096">{{cite journal| author=Kashyap S, Mohapatra PR| title=Pulmonary alveolar microlithiasis. | journal=Lung India | year= 2013 | volume= 30 | issue= 2 | pages= 143-7 | pmid=23741096 | doi=10.4103/0970-2113.110424 | pmc=PMC3669555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23741096 }} </ref> [[pulmonary fibrosis]], [[Langerhans cell histiocytosis]],[[interstitial lung disease]]. | | bgcolor="Beige" | [[Idiopathic pulmonary hemosiderosis]], [[sarcoidosis]], [[primary pulmonary hypertension]], [[pulmonary fibrosis]], [[alveolar capillary dysplasia|alveolar capillary dysplasia with misalignment of pulmonary veins]], [[cystic fibrosis]], [[pulmonary embolism]], [[tropical pulmonary eosinophilia]], [[pulmonary capillary hemangiomatosis]], [[bronchiectasis]],[[bronchopulmonary dysplasia]], [[chronic obstructive pulmonary disease]], pulmonary alveolar microlithiasis,<ref name="pmid23741096">{{cite journal| author=Kashyap S, Mohapatra PR| title=Pulmonary alveolar microlithiasis. | journal=Lung India | year= 2013 | volume= 30 | issue= 2 | pages= 143-7 | pmid=23741096 | doi=10.4103/0970-2113.110424 | pmc=PMC3669555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23741096 }} </ref> [[pulmonary fibrosis]], [[Langerhans cell histiocytosis]],[[interstitial lung disease]]. | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Renal / Electrolyte''' | | '''Renal / Electrolyte''' | ||
|bgcolor="Beige"| [[renal failure|Chronic renal failure]] on [[dialysis]] | | bgcolor="Beige" | [[renal failure|Chronic renal failure]] on [[dialysis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Rheum / Immune / Allergy''' | | '''Rheum / Immune / Allergy''' | ||
|bgcolor="Beige"| [[Vasculitis]], [[Churg-Strauss syndrome]], [[sarcoidosis]], [[systemic sclerosis]], [[systemic lupus erythematosus]]. | | bgcolor="Beige" | [[Vasculitis]], [[Churg-Strauss syndrome]], [[sarcoidosis]], [[systemic sclerosis]], [[systemic lupus erythematosus]]. | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Sexual''' | | '''Sexual''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Urologic''' | | '''Urologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| [[Gaucher disease]], [[glycogen storage diseases]], [[scoliosis|idiopathic spinal scoliosis]], | | bgcolor="Beige" | [[Gaucher disease]], [[glycogen storage diseases]], [[scoliosis|idiopathic spinal scoliosis]], | ||
|- | |- | ||
|} | |} |
Revision as of 15:24, 28 February 2018
Pulmonary Hypertension Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pulmonary hypertension causes On the Web |
American Roentgen Ray Society Images of Pulmonary hypertension causes |
Risk calculators and risk factors for Pulmonary hypertension causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ralph Matar; Mohamed Moubarak, M.D. [2]
Overview
Pulmonary hypertension can be classified into primary pulmonary hypertension (of unknown cause) which is currently known as idiopathic pulmonary arterial hypertension (IPAH) and secondary pulmonary hypertension due to another medical condition. The most common cause of pulmonary hypertension is left heart failure. Other common causes include HIV, systemic sclerosis, portal hypertension, congenital heart disease and sickle cell disease.[1]
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Pulmonary hypertension itself is not a life threatening condition, but it is progressively fatal if left untreated. Pulmonary embolism and acute left heart failure are two causes of pulmonary hypertension that can be quickly fatal.
Common Causes
The most common cause of pulmonary hypertension is left heart failure leading to pulmonary venous hypertension. Other Common causes of pulmonary arterial hypertension (PAH) include:
- Cor pulmonale (Right heart failure due to pulmonary disease)
- Congestive heart failure
- Congenital heart disease
- COPD
- Familial Pulmonary Hypertension
- HIV
- Interstitial lung disease
- Mitral stenosis
- Obstructive sleep apnea
- Portal hypertension
- Pickwickian syndrome
- Right sided valvular disease
- Systemic sclerosis
- Sickle cell disease[1]
Idiopathic Pulmonary Arterial Hypertension
When none of the causes on this page can be found, the disease is termed idiopathic pulmonary arterial hypertension (IPAH).
Causes by Organ System
Causes in Alphabetical Order
Causes by Clinical Classification
Class 1: Pulmonary arterial hypertension
- Idiopathic pulmonary arterial hypertension
- Heritable (BMPR2, ALK-1, ENG, SMAD9, CAV1, KCNK3)
- Drug and toxin induced
Class 2: Pulmonary hypertension due to left heart disease
- Left ventricular systolic dysfunction
- Left ventricular diastolic dysfunction
- Valvular disease
- Congenital/acquired left heart inflow/outflow tract obstruction and congenital cardiomyopathies
Class 3: Pulmonary hypertension due to lung diseases and/or hypoxia
- Chronic obstructive pulmonary disease
- Interstitial lung disease
- Other pulmonary diseases with mixed restrictive and obstructive pattern
- Sleep-disordered breathing
- Alveolar hypoventilation disorders
- Chronic exposure to high altitude
- Developmental lung diseases
Class 4: Chronic thromboembolic pulmonary hypertension
Class 5: Pulmonary hypertension with unclear multifactorial mechanisms
- Hematologic disorders: chronic hemolytic anemia, Myeloproliferative disorders, splenectomy,
- Systemic disorders: sarcoidosis, pulmonary histiocytosis, lymphangioleiomyomatosis
- Metabolic disorders: glycogen storage disease, Gaucher disease, thyroid disorders
- Miscellaneous: tumoral obstruction, fibrosing mediastinitis, chronic renal failure, segmental PH
References
- ↑ 1.0 1.1 Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K; et al. (2004). "Pulmonary hypertension as a risk factor for death in patients with sickle cell disease". N Engl J Med. 350 (9): 886–95. doi:10.1056/NEJMoa035477. PMID 14985486.
- ↑ 2.0 2.1 Nayak NC, Chitale AR (2013). "Indian childhood cirrhosis (ICC) & ICC-like diseases: the changing scenario of facts versus notions". Indian J Med Res. 137 (6): 1029–42. PMC 3734708. PMID 23852284.
- ↑ 3.0 3.1 Schultze AE, Roth RA (1998). "Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system". J Toxicol Environ Health B Crit Rev. 1 (4): 271–346. doi:10.1080/10937409809524557. PMID 9776954.
- ↑ 4.0 4.1 Kashyap S, Mohapatra PR (2013). "Pulmonary alveolar microlithiasis". Lung India. 30 (2): 143–7. doi:10.4103/0970-2113.110424. PMC 3669555. PMID 23741096.